Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
                        
                            
                                申请人:Nimbus Saturn, Inc.
                            
                            
                                公开号:US11078201B2
                            
                            
                                公开(公告)日:2021-08-03
                            
                            
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
                            本发明提供了用于抑制 HPK1 和治疗 HPK1 介导的疾病的化合物、其组合物和使用方法。